InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

Biotechnology

InflaRx

Niels C. Riedemann

Michelle Medovich

Camilla Chong

Anja Pfaff

Timothy E. Hermes

Daniel Vetter

Jacky Schmitt

Renfeng Guo

Thomas Taapken

Nicole Bertsch

Mark Kubler

Nicolas Fulpius

Tony Gibney

Richard Brudnick

Hege Hellstrom

The Research & Development team at InflaRx is responsible for advancing the company's pipeline of anti-C5a therapies through its stages from discovery to clinical application. This multidisciplinary team conducts preclinical research, drug discovery, pharmacovigilance, and clinical pharmacokinetics to ensure the safety, efficacy, and quality of new therapeutics aimed at treating inflammatory and autoimmune diseases.

Research & Development

The Medical and Scientific Affairs team at InflaRx is responsible for bridging clinical insights and scientific research, ensuring the successful development and application of the company’s anti-C5a technology. They lead medical strategy, oversee clinical research, and provide scientific expertise to support regulatory submissions and clinical trials, with a focus on innovative treatments for conditions mediated by C5a signaling pathways.

Medical and Scientific Affairs

The Human Resources and Administrative team at InflaRx is responsible for managing employee relations, staffing, and organizational development. They also oversee IT infrastructure, ensure the quality and delivery of clinical trial supplies, and lead digital transformation initiatives to support the company's clinical-stage biopharmaceutical operations.

Human Resources and Administrative

The Leadership Team at InflaRx guides the strategic vision and operational execution of the company, focusing on advancing its innovative anti-C5a therapies. Comprising seasoned executives with expertise in scientific research, financial management, and corporate development, the team collaborates to drive clinical advancements, secure funding, and navigate regulatory pathways, ensuring the successful progression of its biopharmaceutical pipeline.

Leadership Team

The Finance and Commercial team at InflaRx is responsible for overseeing the company’s financial health, driving commercial strategy, and ensuring effective financial planning and analysis. This includes budget management, financial reporting, market analysis, and the development of business strategies to support the commercial launch and growth of InflaRx’s proprietary anti-C5a technology.

InflaRx

Org chart

Board & advisors

Teams

Research & Development

Medical and Scientific Affairs

Human Resources and Administrative

Leadership Team

Finance and Commercial

Offices

InflaRx

Org chart

Board & advisors

Teams

Research & Development

Medical and Scientific Affairs

Human Resources and Administrative

Leadership Team

Finance and Commercial

Offices

Related companies